Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afek, A
Right arrow Articles by Kopolovic, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Afek, A
Right arrow Articles by Kopolovic, J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 8, No. 7, 502-507 (1999)
DOI: 10.1191/096120399678840873

Increased endothelial cell expression of a3ß1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome

A Afek

Institute of Pathology, Department of Medicine ‘B’; Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

Y Shoenfeld

R Manor

Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

I Goldberg

Institute of Pathology, Department of Medicine ‘B’; Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

L Ziporen

J George

Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

S Polak-Charcon

Institute of Pathology, Department of Medicine ‘B’; Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

M C Amigo

Departments of Rheumatology; Instituto Nacional de Cardiologia ‘Ignacio Chavez’, Mexico

R Garcia-Torres

Department of Pathology, Instituto Nacional de Cardiologia ‘Ignacio Chavez’, Mexico

R Segal

Department of Rehabilitation, Shmuel Harofeh, Beer Jacob, Israel

J Kopolovic

Institute of Pathology, Department of Medicine ‘B’; Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

The objective of this work was to determine markers of endothelial cell activation in valves from patients with antiphospholipid syndrome (APS) and heart valve involvement, in order to establish a role for endothelial cells in the pathogenesis of the valvular disease.

Sixteen valves from ten patients with APS, obtained from autopsies or removed during valve replacement, were studied. Two groups of valves were used as controls. One group included seven normal valves from patients who died from non-cardiac diseases. The other group of valves were obtained from patients with bacterial endocarditis during autopsies or valve replacement operations.

Immunoperoxidase and immunofluorescence stainings with antibodies to human immunoglobulins, endothelial cells, a3ß1 integrin, collagen IV, laminin and fibronectin were employed.

Three histopathological patterns were apparent: normal valves, valves with verrucous endocarditis and valves with fibrocalcific changes. In all the valves with verrucous endocarditis the following findings were observed: (1) increased expression of the a3ß1 integrin on the endothelial cells, (2) increased amount of collagen IV, laminin and fibronectin, (3) proliferation of blood vessels and (4) linear subendothelial deposition of immunoglobulins and complement. The valves with fibrocalcific changes were deformed and showed a thick layer of collagen IV, laminin and fibronectin, yet in two valves the indothelial cells showed an expression of the a3ß1 integrin. The control valves did not express the integrin and had only a thin subendothelial band of collagen IV.

In valves from patients with APS,1 markers of endothelial cell activation are upregulated while the inflammatory exudate is scant. There is also a prominent deposition of immunoglobulins in the valves from patients with APS, suggesting a possible association between the deposition of the antibodies and the activation of the endothelial cells in APS.

Key Words: Libman–Sacks endocarditis • antiphospholipid syndrome • systemic lupus syndrome • systemic lupus erythematosus • basement membrane • anti-cardiolipin antibodies • integrins


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Gorki, V. Malinovski, and R. D.L. Stanbridge
The antiphospholipid syndrome and heart valve surgery
Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 168 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Dinkla, D. P. Nitsche-Schmitz, V. Barroso, S. Reissmann, H. M. Johansson, I.-M. Frick, M. Rohde, and G. S. Chhatwal
Identification of a Streptococcal Octapeptide Motif Involved in Acute Rheumatic Fever
J. Biol. Chem., June 29, 2007; 282(26): 18686 - 18693.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
I Krause, S Lev, A Fraser, M Blank, M Lorber, L Stojanovich, J Rovensky, J Chapman, and Y Shoenfeld
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome
Ann Rheum Dis, October 1, 2005; 64(10): 1490 - 1493.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Tincani, C Biasini-Rebaioli, R Cattaneo, and P Riboldi
Nonorgan specific autoantibodies and heart damage
Lupus, September 1, 2005; 14(9): 656 - 659.
[Abstract] [PDF]


Home page
LupusHome page
F Tenedios, D Erkan, and M D Lockshin
Cardiac involvement in the antiphospholipid syndrome
Lupus, September 1, 2005; 14(9): 691 - 696.
[Abstract] [PDF]


Home page
LupusHome page
M Blank, A Aron-Maor, and Y Shoenfeld
From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?
Lupus, September 1, 2005; 14(9): 697 - 701.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Berkun, A. Elami, K. Meir, D. Mevorach, and Y. Naparstek
Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R L Bates, S J Payne, S L Drury, P N Nelson, D A Isenberg, J J Murphy, and G Frampton
The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus
Lupus, August 1, 2003; 12(8): 617 - 622.
[Abstract] [PDF]


Home page
LupusHome page
T Wolak, M Abu-Shakra, D Flusser, N Liel-Cohen, D Buskila, and S Sukenik
Kingella endocarditis and meningitis in a patient with SLE and associated antiphospholipid syndrome
Lupus, June 1, 2000; 9(5): 393 - 396.
[Abstract] [PDF]